GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid Cancer Cell Lines through MYCN Downregulation

Anaplastic thyroid cancer (ATC) is a very rare, but extremely aggressive form of thyroid malignancy, responsible for the highest mortality rate registered for thyroid cancer. Treatment with taxanes (such as paclitaxel) is an important approach in counteracting ATC or slowing its progression in tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Molteni, Elisabetta, Baldan, Federica, Damante, Giuseppe, Allegri, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054879/
https://www.ncbi.nlm.nih.gov/pubmed/36983070
http://dx.doi.org/10.3390/ijms24065993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054879/
https://www.ncbi.nlm.nih.gov/pubmed/36983070
http://dx.doi.org/10.3390/ijms24065993

Ejemplares similares